Nanhua Bio-Medicineco.Ltd(000504) independent director
Opinions on relevant matters of the third meeting of the 11th board of directors
In accordance with laws, regulations and normative documents such as the company law, the standards for the governance of listed companies, the rules for independent directors of listed companies, the guidelines for self discipline supervision of listed companies of Shenzhen Stock Exchange No. 1 – standardized operation of listed companies on the main board, as well as the articles of association, the rules of procedure of the board of directors and other relevant provisions, As an independent director of Nanhua Bio-Medicineco.Ltd(000504) (hereinafter referred to as “the company”), after careful review, he issued the following agreed opinions on relevant matters of the third meeting of the 11th board of directors of the company:
1. Opinions on the remuneration scheme of directors and senior managers of the company
The remuneration plan of directors and senior managers shall be proposed and formulated by the remuneration and assessment committee of the board of directors and submitted to the board of directors of the company for deliberation, and the management of the company shall be authorized to handle matters related to the formulation of annual remuneration and assessment regulations for directors and senior managers. After the specific plan is formulated by the human resources department, it shall be submitted to the remuneration and assessment committee of the board of directors for deliberation. The above deliberation and decision-making procedures comply with the relevant provisions of the company law, the articles of association, etc. Therefore, we agree to submit the relevant issues of this matter to the general meeting of shareholders of the company for deliberation.
2. Opinions on purchasing the liability insurance of directors, supervisors and senior managers
The company’s purchase of liability insurance for all directors, supervisors and senior managers is conducive to improving the company’s risk control system, protecting the rights and interests of the company and its directors, supervisors and senior managers, promoting the relevant responsible personnel to fully exercise their rights and perform their duties, and promoting the healthy development of the company, without damaging the interests of the company and all shareholders. The board of directors of the company avoided voting on the matter and submitted it to the general meeting of shareholders of the company for deliberation. The deliberation procedures comply with the company law, the articles of association and other relevant provisions.
Nanhua Bio-Medicineco.Ltd(000504) independent director: vinegar Weihua, Zhao Yaqing, Zhao Ping
January 26, 2022
